Barry C. Buckland
Executive Director, National Institute for Innovation in Manufacturing Pharmaceuticals
Barry C. Buckland, Ph.D., is executive director of the National Institute for Innovation in Manufacturing Pharmaceuticals and CEO at BiologicB, a consultancy specializing in biotechnology. He was elected to the National Academy of Engineering in 1997. Over three decades at Merck Research Laboratories (MRL), Buckland built the bioprocess R&D group, leading the development of all biologically made product candidates within the MRL pipeline and the manufacture of clinical supplies. He is a visiting professor at University College London, where he earned his doctorate in Biochemical Engineering.
OPINION – Offshoring and outsourcing antibiotic production to China and India is putting America’s access to lifesaving medicines at risk. It’s time to implement antibiotic security measures before a [...] More
